Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kalafatis

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
The Journal of Applied Laboratory Medicine|July 9, 2021
COVID-19: A Serious Vascular Disease with Primary Symptoms of a Respiratory AilmentMichael Kalafatis
Current Opinion in Hematology|February 24, 2005
Coagulation factor V: a plethora of anticoagulant moleculesMichael Kalafatis
ACS Omega|December 19, 2017
Spellbinding Effects of the Acidic COOH-Terminus of Factor Va Heavy Chain on Prothrombinase Activity and FunctionJamila Hirbawi, Michael Kalafatis
Blood|October 24, 2002
Factor V: a combination of Dr Jekyll and Mr HydeKenneth G Mann, Michael Kalafatis
Biochemistry|July 10, 2002
Sequencing of full-length cDNA encoding the alpha and beta subunits of human casein kinase II from human platelets and megakaryocytic cells. Expression of the casein kinase IIalpha intronless gene in a megakaryocytic cell lineLisam S Singh, Michael Kalafatis
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 7, 2011
Cleavage at both Arg306 and Arg506 is required and sufficient for timely and efficient inactivation of factor Va by activated protein CMelissa A Barhoover, Michael Kalafatis
Anticancer Research|December 4, 2018
Ursolic Acid Promotes the Sensitization of rhTRAIL-resistant Triple-negative Breast CancerJasmine M Manouchehri, Michael Kalafatis
Biochemistry|October 16, 2002
Identification of a binding site for blood coagulation factor Xa on the heavy chain of factor Va. Amino acid residues 323-331 of factor V represent an interactive site for activated factor XMichael Kalafatis, Daniel O Beck
The Journal of Applied Laboratory Medicine|July 8, 2020
The Case Back on the TRAIL: Death Receptors as Markers for rhTRAIL SensitivityKatherine A Turner, Michael Kalafatis
Anticancer Research|December 1, 2017
Sensitization of rhTRAIL-resistant Triple-negative Breast Carcinoma Through Silibinin Co-TreatmentJasmine M Manouchehri, Michael Kalafatis
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Applied Laboratory Medicine|July 9, 2021
COVID-19: A Serious Vascular Disease with Primary Symptoms of a Respiratory AilmentMichael Kalafatis
Current Opinion in Hematology|February 24, 2005
Coagulation factor V: a plethora of anticoagulant moleculesMichael Kalafatis
ACS Omega|December 19, 2017
Spellbinding Effects of the Acidic COOH-Terminus of Factor Va Heavy Chain on Prothrombinase Activity and FunctionJamila Hirbawi, Michael Kalafatis
Blood|October 24, 2002
Factor V: a combination of Dr Jekyll and Mr HydeKenneth G Mann, Michael Kalafatis
Biochemistry|July 10, 2002
Sequencing of full-length cDNA encoding the alpha and beta subunits of human casein kinase II from human platelets and megakaryocytic cells. Expression of the casein kinase IIalpha intronless gene in a megakaryocytic cell lineLisam S Singh, Michael Kalafatis
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 7, 2011
Cleavage at both Arg306 and Arg506 is required and sufficient for timely and efficient inactivation of factor Va by activated protein CMelissa A Barhoover, Michael Kalafatis
Anticancer Research|December 4, 2018
Ursolic Acid Promotes the Sensitization of rhTRAIL-resistant Triple-negative Breast CancerJasmine M Manouchehri, Michael Kalafatis
Biochemistry|October 16, 2002
Identification of a binding site for blood coagulation factor Xa on the heavy chain of factor Va. Amino acid residues 323-331 of factor V represent an interactive site for activated factor XMichael Kalafatis, Daniel O Beck
The Journal of Applied Laboratory Medicine|July 8, 2020
The Case Back on the TRAIL: Death Receptors as Markers for rhTRAIL SensitivityKatherine A Turner, Michael Kalafatis
Anticancer Research|December 1, 2017
Sensitization of rhTRAIL-resistant Triple-negative Breast Carcinoma Through Silibinin Co-TreatmentJasmine M Manouchehri, Michael Kalafatis
Pageof 4